Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Gp VII Llc Orbimed currently holds 7,833,869 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp VII Llc Orbimed has been a net buyer of ELVN stock. They have purchased $99.6M and sold $31.3M worth of shares.
Capital Gp VII Llc Orbimed's most recent insider trade was on Nov 1, 2024, when they sold 215,146 shares at $0.00 per share.
Capital Gp VII Llc Orbimed serves as Executive at Enliven Therapeutics, Inc. (ELVN). They have executed 68 insider transactions totaling $130.9M over their tenure at the company.
Capital Gp VII Llc Orbimed holds the position of Executive at Enliven Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Capital Gp VII Llc Orbimed has shown a buying trading pattern, with $99.6M in total purchases and $31.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Capital Gp VII Llc Orbimed was on May 16, 2024, when they sold $22.1M worth of ELVN shares. This transaction involved 1,000,000 shares at $22.14 per share.
Capital Gp VII Llc Orbimed currently owns 7,833,869 shares of Enliven Therapeutics, Inc. (ELVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Gp VII Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Gp VII Llc Orbimed has 68 Form 4 filings on record as an insider at Enliven Therapeutics, Inc..
Set alerts for Capital Gp VII Llc Orbimed and 40,000+ other insiders.